Polyclonal BRAF mutations in melanoma
Author Information
Author(s): Lin J, Goto Y, Murata H, Sakaizawa K, Uchiyama A, Saida T, Takata M
Primary Institution: Shinshu University School of Medicine
Hypothesis
Does heterogeneity of BRAF mutations exist in primary melanomas?
Conclusion
BRAF mutations are not a founder event in melanoma development but are selected for during progression.
Supporting Evidence
- Four of five primary melanomas contained both BRAF-wild-type and BRAF-mutant tumor cells.
- Selection of BRAF mutant alleles during progression was demonstrated in all three patients.
- Eight of ten primary melanomas showed tumor heterogeneity in terms of BRAF mutations.
Takeaway
Melanomas can have many different BRAF mutations, and these mutations can change as the cancer grows.
Methodology
Single melanoma cells were isolated and sequenced from primary melanoma tissues, and BRAF mutations were analyzed using various assays.
Potential Biases
Potential bias in sample selection and mutation detection methods.
Limitations
The study may not account for all possible mutations in melanoma due to the focus on specific BRAF mutations.
Participant Demographics
Patients included 17 individuals with primary and metastatic melanoma.
Statistical Information
P-Value
0.012
Statistical Significance
p=0.012
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website